Immunosuppression

Does nintedanib have the same effect on FVC decline in patients with progressive fibrosing ILDs treated with DMARDs or glucocorticoids?
Nazia Chaudhuri, Vincent Cottin, Stefania Cerri, Michael Kreuter, Maria Otaola, Diego Castillo Villegas, Craig Glazer, Heiko Müller, Carl Coeck, Manuel Quaresma, Toby M Maher

European Respiratory Journal Sep 2020, 56 (suppl 64) 4576; DOI: 10.1183/13993003.congress-2020.4576
Methotrexate and risk of Lung disease in Rheumatoid Arthritis: A nationwide population-based cohort study from Denmark
Saher Burhan Shaker, Else Helene Ibfelt, Rikke Kart Jacobsen, Tine Iskov Kopp, René Lindholm Cordtz, Anna Svarre Jakobsen, Niels Seersholm, Lene Dreyer

European Respiratory Journal Sep 2020, 56 (suppl 64) 4574; DOI: 10.1183/13993003.congress-2020.4574
The use of mTOR inhibitors is associated with improved survival in lung transplant recipients
Yael Lebel-Shostak, Barak Pertzov, Ori Grossberger, Dror Rosengarten, Dorit Shitenberg, Moshe Heshing, Shai Amor, Mordechai Kramer

European Respiratory Journal Sep 2020, 56 (suppl 64) 4724; DOI: 10.1183/13993003.congress-2020.4724
Real life experience in mTOR-inhibitors after lung transplantation
Saskia Bos, Laurens De Sadeleer, Bart Vanaudenaerde, Jonas Yserbyt, Lieven Dupont, Laurent Godinas, Geert Verleden, Robin Vos

European Respiratory Journal Sep 2020, 56 (suppl 64) 4725; DOI: 10.1183/13993003.congress-2020.4725
Immune alveolitis profile in bronchoalveolar lavage of infiltrative lung diseases: not just counting matters
Antoine Moui, Stéphanie Dirou, Christine Sagan, Renan Liberge, Claire Defrance, Pierre-Paul Arrigoni, Olivier Morla, Christine Kandel-Aznar, Adrien Tissot, Emmanuel Eschapasse, Thomas Goronflot, Antoine Magnan, François-Xavier Blanc

European Respiratory Journal Sep 2020, 56 (suppl 64) 3531; DOI: 10.1183/13993003.congress-2020.3531
Venous thromboembolism in solid-organ transplant recipients: findings from the RIETE registry
Alberto Garcia Ortega, Raquel López Reyes, Gabriel Anguera De Francisco, Grace Oscullo Yépez, Remedios Otero Candelera, Manuel López-Meseguer, Andrés Quezada, Luis Jara-Palomares, Manuel Monreal

European Respiratory Journal Sep 2020, 56 (suppl 64) 3571; DOI: 10.1183/13993003.congress-2020.3571
Criteria for PF-ILD in a cohort of patients with chronic hypersensitivity pneumonitis
Eduarda Salomé Soares Seixas, Paula Serra, Margarida Ferreira, Renata Aguiar, Pedro Gonçalo Ferreira

European Respiratory Journal Sep 2020, 56 (suppl 64) 3538; DOI: 10.1183/13993003.congress-2020.3538
DIAGNOSTICS, THERAPY, COURSE AND RESULTS IN PATIENTS WITH CHRONIC EXTRINSIC ALLERGIC ALVEOLITIS
Francesco Bini, Daniele Colombo, Maria Chiara Papetti, Bruno Bodini, Angelo De Lauretis, Adriano Vaghi

European Respiratory Journal Sep 2020, 56 (suppl 64) 3478; DOI: 10.1183/13993003.congress-2020.3478
Rheumatoid arthritis-related interstitial lung disease (RA-ILD): Clinical, functional features, and variables associated poor initial prognosis in a chilean cohort
Felipe Reyes, Silvana Saavedra, Karen Vergara, Matias Florenzano, Veronica Wolff

European Respiratory Journal Sep 2020, 56 (suppl 64) 3481; DOI: 10.1183/13993003.congress-2020.3481
Extracorporeal membrane oxygenation for adults with active malignancy: Is there difference to clinical outcome between hematologic and oncologic?
Chul Park, Eun Taek Jung, Ki Eun Hwang, Jae Wan Jung, Hyun Im, Hak Ryul Kim

European Respiratory Journal Sep 2020, 56 (suppl 64) 3440; DOI: 10.1183/13993003.congress-2020.3440

Main menu

User menu

Search

Immunosuppression

Pages

Contact us